Magma Fincorp also said that Vijay Deshwal, a seasoned banker with a track record of over two decades, will take charge as the company s CEO from the first week of July.
The Pune-based Serum Institute of India (SII) has ramped up production of COVID-19 vaccine and will provide 10 crore doses of Covishield to the Centre by the next month and a further 10 to 12 crore doses by July.
Amid growing concern for when children will be vaccinated against coronavirus, the approval of Bharat Biotech s Covaxin for clinical trials on children above the age of.
In the first of its kind study since the launch of the AstraZeneca s Covishield and Bharat Biotech s Covaxin in the country, the Indian Council of Medical Research (ICMR) will conduct a survey from next week to examine the effectiveness of these vaccines in preventing progression of COVID into a severe form.
Around 4,000 people above the age of 45 years who have taken either one or both doses of any of these two vaccines will be reviewed, according to Dr Tarun Bhatnagar, senior scientist at ICMR s National Institute of Epidemiology (NIE) in Chennai. As a part of the study we will take people who are COVID-19 positive and hospitalised and compare their vaccination status with those who have tested COVID negative, Bhatnagar told PTI.
The Indian Council of Medical Research (ICMR) will commence a study to examine the effectiveness of AstraZeneca's Covishield and Bharat Biotech's Covaxin from next week.